# Estrella Immunopharma, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 10-K/A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 17:27 ET
- Period: 2025-12-31
- Accession: 0001213900-26-050433
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000121390026050433/ea0288591-10ka1_estrella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000121390026050433/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000121390026050433/ea0288591-10ka1_estrella.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-050433. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.